GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the human rage VC1 fragment in space group P62

Analyse Crystal structure of the human rage VC1 fragment in space group P62 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4LP4
Type
protein
Length
424 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Advanced glycosylation end product-specific receptor
UniProt
Q15109
Ligands
NA
Pockets
7 · best druggability 0.45

Structure

x-ray diffraction · 1 distinct chain · 3% helix, 48% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BAdvanced glycosylation end product-specific receptorprotein2123% helix, 48% strandQ15109

Ligands and binding sites

  • NA · Sodium ion · metal · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11040.450.7819empty
21020.430.7819empty
31380.400.7423empty
41510.390.7325empty
5860.320.7317empty

Interfaces

1 interface between chains.

  • A–B · 572 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 4LP4 · Crystal structure of the human RAGE VC1 fragment in space group P62 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q15109 · AlphaFold monomer V2.0 prediction for advanced glycosylation end product-specific… · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.